The release of the BAP1 assay follows other recent launches like VENTANA MTAP and Claudin-4 to create a robust suite of diagnostic tools for lung health. Pathologists have long navigated the significant difficulty of differentiating between malignant mesothelioma and benign reactive processes in
The staggering reality of lung cancer in Malaysia is underscored by the fact that nearly nine individuals are diagnosed with this life-threatening condition every single day. Recent data from the Malaysian National Cancer Registry highlights a deeply concerning trend where lung cancer has
Surgeons often struggle with the decision of how aggressive a neck dissection should be when preoperative ultrasound provides ambiguous information about nodal involvement. This dilemma is particularly acute in the management of differentiated thyroid cancer, where papillary thyroid carcinoma (PTC)
While 6Ga-PSMA and 18F-DCFPyL are cornerstones of modern prostate cancer diagnostics, their effectiveness is limited by the respiratory 'blur' that occurs in the chest and abdomen. This phenomenon is a persistent technical obstacle in nuclear medicine because Positron Emission Tomography/Computed
Medical researchers at the University of Vienna are investigating whether dual-modality imaging can accurately identify which patients with elevated PSA levels truly require a biopsy. For decades, the standard protocol for suspected prostate cancer has relied heavily on the Prostate-Specific
Severe exertional dyspnea and intestinal obstruction marked the final stages of the patient's seventeen-month battle with this rare and invasive form of urethral malignancy. Primary urethral carcinoma remains one of the most elusive and devastating urological conditions, accounting for less than
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66
